Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.440
+0.190 (5.85%)
Apr 1, 2026, 1:05 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.12 billion as of April 2, 2026. Its market cap has increased by 51.68% in one year.
Market Cap
1.12B
Enterprise Value
541.27M
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.44
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.12B, a decrease of -79.66%. That is a compound annual growth rate of -22.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 1.12B | 42.62% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.32B |
| Thor Medical ASA | 1.77B |
| ArcticZymes Technologies ASA | 1.00B |
| Lytix Biopharma AS | 799.76M |
| Zelluna ASA | 493.35M |
| SoftOx Solutions AS | 275.20M |
| Oncoinvent ASA | 209.23M |
| Aqua Bio Technology ASA | 106.39M |